🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Atopic Dermatitis
Clinical trial register · France

Atopic Dermatitis Trials in France, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9693 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:56 UTC
9693
Studies in scope
all four open statuses
6031
Recruiting now
open to new participants
1035
Lead sponsors
across recruiting studies
Top sites
Bordeaux 6 Rouen 5 Besançon 4 Romans-sur-Isère 4 Amiens 4
Narrow the registerReset
Recruitment status
Phase
Site location
Bordeaux6 Rouen5 Besançon4 Romans-sur-Isère4 Amiens4
All 44 locations
Target enrolment
to

Atopic Dermatitis trials in France

19 of 9693 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
NCT07216027Atopic Dermatitis, Eczema, Atopic
Pfizer
Phase 2
165
Rouen, Toulouse
2025-11-20
Recruiting
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
NCT07290803Atopic Dermatitis
Sanofi
Observational
1,000
Besançon, Valence, Mulhouse, Saint-Pierre, Romans-sur-Isère, Chalon-sur-Saône, Le Mans
2025-11-17
Active, closed
Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis
NCT07220577Atopic Dermatitis
DrugGIA632
Novartis Pharmaceuticals
Phase 2
34
Antony, Dijon, Martigues, Nice
2025-11-10
Recruiting
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
NCT06599411Atopic Dermatitis, Psoriasis, Hidradenitis Suppurativa, Lichen Planus
Assistance Publique - Hôpitaux de Paris
Observational
830
Paris
2025-10-20
Active, closed
A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis
NCT06832618Atopic Dermatitis
Incyte Corporation
Phase 3
159
Bordeaux, Reims, Romans-sur-Isère
2025-06-17
Recruiting
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
NCT06947993Atopic Dermatitis
Novartis Pharmaceuticals
Phase 2
224
Brest, Lille, Lorient, Paris, Pierre-Bénite, Reims, Rouen
2025-05-16
Active, closed
A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis
NCT06863961Atopic Dermatitis
Hoffmann-La Roche
Phase 2
162
Rouen, Cedex 10
2025-04-01
Recruiting
French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)
NCT06837454Atopic Dermatitis
Sanofi
Observational
600
Aix-en-Provence, Amiens, Angers, Arès, Bayonne, Bezannes, Biarritz, Bordeaux
2025-02-04
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
NCT06461897Atopic Dermatitis
AbbVie
Phase 3
675
Toulouse, Vandœuvre-lès-Nancy, Bordeaux, Nantes, Clermont-Ferrand, Amiens, Paris, Argenteuil
2024-08-19
Active, closed
A Study Evaluating APG777 in Atopic Dermatitis
NCT06395948Atopic Dermatitis
DrugAPG777
Apogee Therapeutics, Inc.
Phase 2
470
Rouen, Martigues, Nantes
2024-04-29
Active, closed
A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving Dupilumab
NCT06169527Atopic Dermatitis
Sanofi
Observational
303
Amiens, Angers, Argenteuil, Armentières, Arras, Ars-Laquenexy, Avignon, Besançon
2023-11-28
Active, closed
Dynamic Blood Inflammatory Profile in Atopic Dermatitis Patients (ADAMUNE)
NCT05868824Atopic Dermatitis
Centre Hospitalier Universitaire de Nice
Not applicable
11
Nice
2023-06-01
Recruiting
A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.
NCT05689151Atopic Dermatitis, Eczema
Pfizer
Observational
183
Amiens, Besançon, Bezannes, Bordeaux, Brest, Caen, Calais, Chalon-sur-Saône
2023-03-09
By invitation
A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
NCT05735483Atopic Dermatitis, Eczema
Eli Lilly and Company
Phase 3
333
Romans-sur-Isère, Lille, Nantes, Toulouse
2023-03-09
Active, closed
An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World
NCT05669794Atopic Dermatitis
AbbVie
Observational
300
Saint-Quentin, Clermont, Marseille, Rennes, Dijon, Niort, Besançon, Romans-sur-Isère
2023-02-21
Recruiting
Frequency of Palpebral Involvement in Adult With Atopic Dermatitis
NCT04826744Atopic Dermatitis
University Hospital, Lille
Observational
550
Lille, Rouen
2021-09-01
By invitation
Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata
NCT03976622Vitiligo, Psoriasis, Alopecia Areata, Atopic Dermatitis
University Hospital, Bordeaux
Observational
450
Bordeaux
2020-01-14
Active, closed
A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
NCT03568318Atopic Dermatitis
AbbVie
Phase 3
1,533
Nice, Marseille, Tours, Bordeaux, Reims
2018-08-09
Rows per page Showing 1–19 of 19
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-france/condition/atopic-dermatitis

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,693 studies in total at the last sync on 26 Sep 2026, 19:56 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 19 of those studies listing the condition Atopic Dermatitis.

How many Atopic Dermatitis trials are recruiting in France?

9 of the 19 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:56 UTC sync. A further 0 have not yet opened recruitment, 8 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Atopic Dermatitis), 19 studies
PhaseStudiesRecruitingShare
Observational8542.1%
Phase 25226.3%
Phase 34121.1%
Not applicable2110.5%

Most active sponsors

Lead sponsors with the most studies (Atopic Dermatitis)
Lead sponsorStudiesRecruiting
AbbVie31
Sanofi32
Novartis Pharmaceuticals21
Pfizer22
Apogee Therapeutics, Inc.10
Assistance Publique - Hôpitaux de Paris11
Centre Hospitalier Universitaire de Nice10
Eli Lilly and Company10
Hoffmann-La Roche10
Incyte Corporation10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.